NCT03478293
终止
不适用
A Prospective Evaluation of the Second Generation iStent Inject in Open-Angle Glaucoma Subjects on Two Preoperative Topical Ocular Hypotensive Medications
概览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 6
- 试验地点
- 1
- 主要终点
- IOP reduction at 12 and 24 months on same number or fewer medications
概览
简要总结
The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medications.
详细描述
The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medications. Outcomes will be evaluated at 12 and 24 months.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
盲法说明
Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Diagnosed with primary open angle glaucoma (POAG)
- •Subject on two ocular hypotensive medications
排除标准
- •Traumatic, uveitic, neovascular, or angle closure glaucoma
- •Fellow eye already enrolled
结局指标
主要结局
IOP reduction at 12 and 24 months on same number or fewer medications
时间窗: 12 months and 24 months
IOP reduction at 12 and 24 months on same number or fewer medications
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
2 期
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost TherapyGlaucomaNCT01426464Nanduri, Padma, M.D., FACS22
已完成
2 期
A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle GlaucomaPrimary Open-Angle Glaucoma (POAG)Ocular Hypertension (OHT)NCT01917383Inotek Pharmaceuticals Corporation101
已完成
4 期
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or TravoprostOpen-angle GlaucomaNCT01443988Glaukos Corporation101
已完成
4 期
Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive AgentsOpen-angle GlaucomaNCT02873806Glaukos Corporation53
已完成
4 期
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or TravoprostOpen-angle GlaucomaNCT01444040Glaukos Corporation196